Entry |
|
Symbol |
MAP2K1
|
Name |
(RefSeq) dual specificity mitogen-activated protein kinase kinase 1 isoform X1
|
KO |
|
Organism |
mcf Macaca fascicularis (crab-eating macaque)
|
Pathway |
mcf01521 | EGFR tyrosine kinase inhibitor resistance |
mcf04072 | Phospholipase D signaling pathway |
mcf04270 | Vascular smooth muscle contraction |
mcf04550 | Signaling pathways regulating pluripotency of stem cells |
mcf04613 | Neutrophil extracellular trap formation |
mcf04620 | Toll-like receptor signaling pathway |
mcf04650 | Natural killer cell mediated cytotoxicity |
mcf04660 | T cell receptor signaling pathway |
mcf04662 | B cell receptor signaling pathway |
mcf04664 | Fc epsilon RI signaling pathway |
mcf04666 | Fc gamma R-mediated phagocytosis |
mcf04810 | Regulation of actin cytoskeleton |
mcf04914 | Progesterone-mediated oocyte maturation |
mcf04919 | Thyroid hormone signaling pathway |
mcf04928 | Parathyroid hormone synthesis, secretion and action |
mcf04935 | Growth hormone synthesis, secretion and action |
mcf05022 | Pathways of neurodegeneration - multiple diseases |
mcf05163 | Human cytomegalovirus infection |
mcf05166 | Human T-cell leukemia virus 1 infection |
mcf05167 | Kaposi sarcoma-associated herpesvirus infection |
mcf05170 | Human immunodeficiency virus 1 infection |
mcf05207 | Chemical carcinogenesis - receptor activation |
mcf05208 | Chemical carcinogenesis - reactive oxygen species |
mcf05230 | Central carbon metabolism in cancer |
mcf05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Brite |
KEGG Orthology (KO) [BR:mcf00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
102141214 (MAP2K1)
04012 ErbB signaling pathway
102141214 (MAP2K1)
04014 Ras signaling pathway
102141214 (MAP2K1)
04015 Rap1 signaling pathway
102141214 (MAP2K1)
04370 VEGF signaling pathway
102141214 (MAP2K1)
04371 Apelin signaling pathway
102141214 (MAP2K1)
04668 TNF signaling pathway
102141214 (MAP2K1)
04066 HIF-1 signaling pathway
102141214 (MAP2K1)
04068 FoxO signaling pathway
102141214 (MAP2K1)
04072 Phospholipase D signaling pathway
102141214 (MAP2K1)
04071 Sphingolipid signaling pathway
102141214 (MAP2K1)
04024 cAMP signaling pathway
102141214 (MAP2K1)
04022 cGMP-PKG signaling pathway
102141214 (MAP2K1)
04151 PI3K-Akt signaling pathway
102141214 (MAP2K1)
04150 mTOR signaling pathway
102141214 (MAP2K1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
102141214 (MAP2K1)
04148 Efferocytosis
102141214 (MAP2K1)
09143 Cell growth and death
04114 Oocyte meiosis
102141214 (MAP2K1)
04210 Apoptosis
102141214 (MAP2K1)
04218 Cellular senescence
102141214 (MAP2K1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
102141214 (MAP2K1)
04540 Gap junction
102141214 (MAP2K1)
04550 Signaling pathways regulating pluripotency of stem cells
102141214 (MAP2K1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
102141214 (MAP2K1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
102141214 (MAP2K1)
04620 Toll-like receptor signaling pathway
102141214 (MAP2K1)
04650 Natural killer cell mediated cytotoxicity
102141214 (MAP2K1)
04660 T cell receptor signaling pathway
102141214 (MAP2K1)
04662 B cell receptor signaling pathway
102141214 (MAP2K1)
04664 Fc epsilon RI signaling pathway
102141214 (MAP2K1)
04666 Fc gamma R-mediated phagocytosis
102141214 (MAP2K1)
04062 Chemokine signaling pathway
102141214 (MAP2K1)
09152 Endocrine system
04910 Insulin signaling pathway
102141214 (MAP2K1)
04929 GnRH secretion
102141214 (MAP2K1)
04912 GnRH signaling pathway
102141214 (MAP2K1)
04915 Estrogen signaling pathway
102141214 (MAP2K1)
04914 Progesterone-mediated oocyte maturation
102141214 (MAP2K1)
04917 Prolactin signaling pathway
102141214 (MAP2K1)
04921 Oxytocin signaling pathway
102141214 (MAP2K1)
04926 Relaxin signaling pathway
102141214 (MAP2K1)
04935 Growth hormone synthesis, secretion and action
102141214 (MAP2K1)
04919 Thyroid hormone signaling pathway
102141214 (MAP2K1)
04928 Parathyroid hormone synthesis, secretion and action
102141214 (MAP2K1)
04916 Melanogenesis
102141214 (MAP2K1)
09153 Circulatory system
04270 Vascular smooth muscle contraction
102141214 (MAP2K1)
09156 Nervous system
04725 Cholinergic synapse
102141214 (MAP2K1)
04726 Serotonergic synapse
102141214 (MAP2K1)
04720 Long-term potentiation
102141214 (MAP2K1)
04730 Long-term depression
102141214 (MAP2K1)
04722 Neurotrophin signaling pathway
102141214 (MAP2K1)
09158 Development and regeneration
04380 Osteoclast differentiation
102141214 (MAP2K1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102141214 (MAP2K1)
05206 MicroRNAs in cancer
102141214 (MAP2K1)
05205 Proteoglycans in cancer
102141214 (MAP2K1)
05207 Chemical carcinogenesis - receptor activation
102141214 (MAP2K1)
05208 Chemical carcinogenesis - reactive oxygen species
102141214 (MAP2K1)
05230 Central carbon metabolism in cancer
102141214 (MAP2K1)
05231 Choline metabolism in cancer
102141214 (MAP2K1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
102141214 (MAP2K1)
09162 Cancer: specific types
05210 Colorectal cancer
102141214 (MAP2K1)
05212 Pancreatic cancer
102141214 (MAP2K1)
05225 Hepatocellular carcinoma
102141214 (MAP2K1)
05226 Gastric cancer
102141214 (MAP2K1)
05214 Glioma
102141214 (MAP2K1)
05216 Thyroid cancer
102141214 (MAP2K1)
05221 Acute myeloid leukemia
102141214 (MAP2K1)
05220 Chronic myeloid leukemia
102141214 (MAP2K1)
05218 Melanoma
102141214 (MAP2K1)
05211 Renal cell carcinoma
102141214 (MAP2K1)
05219 Bladder cancer
102141214 (MAP2K1)
05215 Prostate cancer
102141214 (MAP2K1)
05213 Endometrial cancer
102141214 (MAP2K1)
05224 Breast cancer
102141214 (MAP2K1)
05223 Non-small cell lung cancer
102141214 (MAP2K1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
102141214 (MAP2K1)
05170 Human immunodeficiency virus 1 infection
102141214 (MAP2K1)
05161 Hepatitis B
102141214 (MAP2K1)
05160 Hepatitis C
102141214 (MAP2K1)
05164 Influenza A
102141214 (MAP2K1)
05163 Human cytomegalovirus infection
102141214 (MAP2K1)
05167 Kaposi sarcoma-associated herpesvirus infection
102141214 (MAP2K1)
05165 Human papillomavirus infection
102141214 (MAP2K1)
09171 Infectious disease: bacterial
05132 Salmonella infection
102141214 (MAP2K1)
05135 Yersinia infection
102141214 (MAP2K1)
09164 Neurodegenerative disease
05010 Alzheimer disease
102141214 (MAP2K1)
05022 Pathways of neurodegeneration - multiple diseases
102141214 (MAP2K1)
09165 Substance dependence
05034 Alcoholism
102141214 (MAP2K1)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
102141214 (MAP2K1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
102141214 (MAP2K1)
01522 Endocrine resistance
102141214 (MAP2K1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:mcf01001]
102141214 (MAP2K1)
Enzymes [BR:mcf01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.12 Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
2.7.12.2 mitogen-activated protein kinase kinase
102141214 (MAP2K1)
Protein kinases [BR:mcf01001]
Serine/threonine kinases: STE group
STE7 family
102141214 (MAP2K1)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
7:join(43045388..43045467,43095834..43096044,43097845..43097991,43106855..43106932,43107933..43107984,43146719..43146843,43149639..43149840,43152242..43152306,43154205..43154266,43154695..43154740,43155467..43155580)
|
AA seq |
393 aa
MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKV
GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE
CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL
REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY
SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY
GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF
IKRSDAEEVDFAGWLCSTIGLHQPSTPTHAAGV |
NT seq |
1182 nt +upstreamnt +downstreamnt
atgcccaagaagaagccgacgcccatccagctgaacccggcccccgacggctccgcggtt
aacgggaccagctctgcggagaccaacttggaggccttgcagaagaagctggaggagcta
gagcttgatgagcagcagcgaaagcgccttgaggcctttctcacccagaagcagaaggtg
ggagaactgaaggatgacgactttgagaagatcagtgagctgggggccggcaatggcggt
gtggtgttcaaggtctcccacaagccttctggcctggtcatggccagaaagctaattcat
ctggagatcaaacccgcaatccggaaccagatcataagggaactgcaggtgctgcatgag
tgcaactctccatacatcgtgggcttctatggtgcattctacagtgatggcgagatcagt
atctgcatggagcacatggatggaggttctctggatcaagtcctgaagaaagctggaaga
attcctgaacaaattttaggaaaagttagcattgctgtaataaaaggcctgacatatctg
agggagaagcacaagatcatgcacagagatgtcaagccctccaacatcctagtcaactcc
cgtggggagatcaagctctgtgactttggggtcagcgggcagctcatcgactccatggcc
aactccttcgtgggcacaaggtcctacatgtcgccagaaagactccaggggactcattac
tctgtgcagtcagacatctggagcatgggactctctctggtagagatggcggttgggagg
tatcccatccctcctccagatgccaaggagctagaactgatgtttgggtgccaggtggag
ggagatgcggctgagaccccacctaggccaaggacccccgggaggccccttagctcatat
ggaatggacagccgacctcccatggcaatttttgagttgttggattacatagtcaacgag
cctcctccgaaattgcccagtggagttttcagtctggaatttcaagattttgtgaataaa
tgcttaataaaaaaccccgcagagagagcagatttgaagcaactcatggttcatgctttt
atcaagagatctgatgctgaggaagtggattttgcaggttggctctgctccactatcggc
cttcaccagcccagcacaccaacccatgctgctggcgtctaa |